Pigment epithelium‑derived factor inhibits advanced glycation end product‑induced proliferation, VEGF and MMP‑9 expression in breast cancer cells via interaction with laminin receptor

  • Authors:
    • Shiori Tsuruhisa
    • Takanori Matsui
    • Yoshinori Koga
    • Ami Sotokawauchi
    • Minoru Yagi
    • Sho-Ichi Yamagishi
  • View Affiliations

  • Published online on: June 30, 2021     https://doi.org/10.3892/ol.2021.12890
  • Article Number: 629
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pigment epithelium‑derived factor (PEDF) is one of the adipocytokines with multifaceted functions, which may serve a role in the development of various types of cardiometabolic disorders. Advanced glycation end products (AGEs) have been shown to contribute to numerous aging‑associated disorders, such as cancer. However, it remains unclear whether and how PEDF exerts antitumor effects in AGE‑exposed human breast cancer MCF‑7 cells, and therefore this was explored in the present study. NADPH oxidase activity was measured with luciferase assay, while gene and protein expression levels were evaluated with quantitative PCR and western blot analysis, respectively. AGEs significantly increased NADPH oxidase‑driven superoxide generation, cytochrome b‑245 β chain (gp91phox) and receptor for AGE (RAGE) mRNA expression, proliferation, mRNA and protein expression levels of vascular endothelial growth factor (VEGF), and matrix metalloproteinase (MMP)‑9 mRNA expression in MCF‑7 cells, all of which were dose‑dependently inhibited by PEDF. Neutralizing antibody against laminin receptor (LR‑Ab) significantly blocked these beneficial effects of PEDF in AGE‑exposed MCF‑7 cells. Furthermore, as in AGE‑treated cells, PEDF dose‑dependently inhibited the NADPH oxidase‑driven superoxide generation, gp91phox, RAGE and MMP‑9 mRNA expression, proliferation, mRNA and protein expression levels of VEGF in non‑treated control MCF‑7 cells, and these effects were also reversed by LR‑Ab. LR levels were not affected by the treatment with AGEs, PEDF or LR‑Ab. The present study suggested that PEDF may exert antitumor effects in AGE‑exposed breast cancer cells by suppressing NADPH oxidase‑induced ROS generation and VEGF and MMP‑9 expression via interaction with LR. Since PEDF expression is decreased in breast cancer tissues, pharmacological upregulation or restoration of PEDF may inhibit the growth and metastasis of breast cancer.
View Figures
View References

Related Articles

Journal Cover

August-2021
Volume 22 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tsuruhisa S, Matsui T, Koga Y, Sotokawauchi A, Yagi M and Yamagishi S: Pigment epithelium‑derived factor inhibits advanced glycation end product‑induced proliferation, VEGF and MMP‑9 expression in breast cancer cells via interaction with laminin receptor. Oncol Lett 22: 629, 2021.
APA
Tsuruhisa, S., Matsui, T., Koga, Y., Sotokawauchi, A., Yagi, M., & Yamagishi, S. (2021). Pigment epithelium‑derived factor inhibits advanced glycation end product‑induced proliferation, VEGF and MMP‑9 expression in breast cancer cells via interaction with laminin receptor. Oncology Letters, 22, 629. https://doi.org/10.3892/ol.2021.12890
MLA
Tsuruhisa, S., Matsui, T., Koga, Y., Sotokawauchi, A., Yagi, M., Yamagishi, S."Pigment epithelium‑derived factor inhibits advanced glycation end product‑induced proliferation, VEGF and MMP‑9 expression in breast cancer cells via interaction with laminin receptor". Oncology Letters 22.2 (2021): 629.
Chicago
Tsuruhisa, S., Matsui, T., Koga, Y., Sotokawauchi, A., Yagi, M., Yamagishi, S."Pigment epithelium‑derived factor inhibits advanced glycation end product‑induced proliferation, VEGF and MMP‑9 expression in breast cancer cells via interaction with laminin receptor". Oncology Letters 22, no. 2 (2021): 629. https://doi.org/10.3892/ol.2021.12890